MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Femasys Inc. Common Stock

FEMY

#3687
Femasys Inc. Common Stock
0.57
0.00%
Sector:
Base:
Profit Currency:
Daily Range
0.57
0.57
Year Range
0.31
1.76
Daily Change
0.00%
Monthly Change
-3.39%
6 month change
+50.00%
Year Change
-65.45%
Previous Close
0.57
Open
0.57
Bid
Ask
Low
0.57
High
0.57
Volume
5
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. FEMY
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
FEMY
2026.02.23
Femasys receives CPT code approval for infertility treatment
Investing Investing
FEMY
2026.02.03
Femasys expands European presence with Swiss distribution deal
Investing Investing
PMCB FEMY
2026.01.15
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Investing Investing
FEMY
2026.01.13
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Investing Investing
PMCB FEMY
2026.01.07
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Investing Investing
PMCB FEMY
2026.01.07
Pharmacyte Biotech CEO Silverman buys $80k in shares
Investing Investing
FEMY
2025.12.18
Femasys receives FDA clearance for FemVue Controlled diagnostic device
Investing Investing
PMCB FEMY
2025.11.25
PharmaCyte Biotech stock soars after successful Femasys stake sale
Investing Investing
FEMY
2025.11.25
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million
Investing Investing
FEMY
2025.11.20
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential
Investing Investing
FEMY
2025.11.03
FDA approves Femasys to continue pivotal trial for non-surgical birth control
Investing Investing
FEMY
2025.10.22
Femasys begins post-market study for non-surgical birth control in EU

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd